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Background: Clinical decision support systems (CDSS) can modify clinician behaviour, yet the factors influencing
their effect remain poorly understood. This study assesses the feasibility and acceptability of a CDSS supporting
diagnostic and treatment decisions for patients with suspected stable angina.
Methods: Intervention The Optimising Management of Angina (OMA) programme includes a CDSS guiding
investigation and medication decisions for clinicians managing patients with new onset stable angina, based on
English national guidelines, introduced through an educational intervention. Design and participants A mixed
methods study i. A study of outcomes among patients presenting with suspected angina in three chest pain clinics
in England before and after introduction of the OMA programme. ii. Observations of clinic processes, interviews and
a focus group with health professionals at two chest pain clinics after delivery of the OMA programme. Outcomes.
Medication and cardiovascular imaging investigations undertaken within six months of presentation, and
concordance of these with the recommendations of the CDSS. Thematic analysis of qualitative data to understand
how the CDSS was used.
Results: Data were analysed for 285 patients attending chest pain clinics: 106 before and 179 after delivery of the
OMA programme. 40 consultations were observed, 5 clinicians interviewed, and a focus group held after the
intervention. The proportion of patients appropriate for diagnostic investigation who received one was 50 %
(95 CI 34–66 %) of those before OMA and 59 % (95 CI 48–70 %) of those after OMA. Despite high use of the CDSS
(84 % of consultations), observations and interviews revealed difficulty with data entry into the CDSS, and structural
and practical barriers to its use. In the majority of cases the CDSS was not used to guide real-time decision making,
only being consulted after the patient had left the room.
Conclusions: The OMA CDSS for the management of chest pain is not feasible in its current form. The CDSS was
not used to support decisions about the care of individual patients. A range of barriers to the use of the CDSS were
identified, some are easily removed, such as insufficient capture of cardiovascular risk, while others are more deeply
embedded in current practice, such as unavailability of some investigations or no prescribing privileges for nurses.
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Clinicians need to use the best available evidence to inform
patient management decisions. Clinical decision support
systems (CDSSs) generate patient-specific assessments or
recommendations to aid clinical decision making. CDSSs
can improve practitioner performance and health care pro-
cesses in a range of clinical scenarios including disease
management, drug-dosing, prescribing and preventive care
[1–3]. The effect of CDSSs on clinical outcomes is less fre-
quently studied. In a systematic review of 148 randomised
controlled trials of CDSSs implemented in clinical settings
only 29 assessed clinical outcomes [1]. There was moderate
evidence in support of an effect of CDSSs on morbidity
from 16 studies; evidence for other clinical outcomes was
of low quality.
Few studies have sought rigorous evidence to determine
what factors contribute to the effectiveness of decision sup-
port systems [4]. A recent meta-regression of computerised
CDSSs found sufficient quality evidence for the assessment
of only six factors. Of these, success of CDSSs was posi-
tively associated with systems developed by the investiga-
tors of the primary studies, systems providing advice to
patients and practitioners, and systems requiring a reason
for overriding advice [5]. It has been argued that research
based on randomised controlled trials is not sufficient to
allow rigorous assessment of the factors that make CDSSs
successful, and that qualitative contextual evaluation and
observation are needed [4].
In the United Kingdom (UK), initial specialist assessment
of suspected angina is undertaken in chest pain clinics.
Chest pain clinics may incorrectly diagnose some patients,
and may not initiate secondary prevention in those with
angina. In a cohort of 8762 patients followed for three years
after attending a chest pain clinic, 33 % of all cardiovascular
events occurred in patients with a diagnosis of non-cardiac
chest pain [6]. This study reported under-prescription of
effective secondary prevention: of those diagnosed with
angina only 28 % were taking a statin [7].
Our Optimising the Management of Angina (OMA)
programme includes a web-based computerised CDSS to
support investigation and medication decisions for patients
with new onset stable chest pain. We hypothesised that
appropriate investigation, leading to accurate diagnosis and
effective secondary prevention, would lead to a reduction in
cardiovascular events. Here we present a mixed methods
study that aimed to understand the factors influencing the
feasibility of the OMA CDSS in clinical practice, and the
impact of the CDSS on investigation and prescribing behav-
iour, to inform potential progression to a cluster rando-
mised trial of the intervention.
Methods
The OMA programme is a complex intervention delivered
at the level of the clinic. The programme has 3 stages:preparation, training and clinic tools (Fig. 1). The prepar-
ation and training stages facilitate use of the OMA CDSS.
The components of the intervention were developed using
behavioural change domains identified by Michie and
colleagues [8].
Design
We used mixed methods, combining a before-and-after
study of chest pain clinic investigation and treatment deci-
sions with observations of clinical practice, interviews and
a focus group. In this paper we report on data collected
directly following incorporation of the CDSS into the
clinics.
Setting and study population
Two hospital trusts (Trust A and Trust B) in a provincial
city recruited chest pain clinic patients both before and
after delivery of the OMA programme. Clinicians with
responsibility for the chest pain clinics in each trust were
identified and approached by members of the research
team. With their agreement a meeting was arranged with
cardiology clinicians and managers to explain the planned
study and obtain agreement to participate. A clinic cham-
pion (senior clinician who agreed to support the interven-
tion) was identified at each trust, and all clinicians working
regularly within the clinic were invited to take part in the
study. Patients were eligible for the study if they had been
referred to the chest pain clinic by their general practi-
tioner. We excluded patients who had a previous
history of cardiovascular disease, and those who did
not speak English. Dates of delivery of the OMA
programme are given in Fig. 1, and study recruitment
is summarised in Fig. 3.
All clinicians working regularly in the chest pain
clinics gave written informed consent to participate in
the qualitative study. Consecutive patients attending the
clinic after incorporation of the CDSS were invited to
give written, informed consent to their consultations
being observed and audio-recorded, and to their medical
records being accessed. All participating patients gave
written informed consent.
The OMA CDSS
The OMA CDSS guides investigation and prescribing
decisions for patients with new onset chest pain. The
CDSS was developed by the research team during
2009/10, and was funded by an NIHR programme grant
(RP-PG-0407-19314). During development of the CDSS,
researchers sought to understand clinicians’ work practices
and decision making within both trusts (Preparation stage).
This process included researchers meeting with the clinic
champion, semi-structured interviews with all regular chest
pain clinicians, and qualitative observation of clinic prac-
tices. Following this, at Trust A the prototype CDSS was
Preparation
Trust A:  July-December 2009 
Trust B:  December 2009-November 2010 
Clinic scoping
An understanding of the clinic context is reached 
through meeting with chest pain clinicians
Clinic champion 
Identification of a clinician to support and 
champion the intervention
Training
Trust A:  March 2010
Trust B:  January 2011
Education sessions
Drawing on behaviour change theory, a session 
to promote use of the clinic tools
Clinic tools
Trust A:  July-November 2010 
Trust B:  January-May 2011 
Computerised Clinical Decision Support System (CDSS):  web 
based tool offering guidance on prescribing and investigation
GP letter modified to give prominence to medication  
recommendations and behavioural advice
Patient leaflets
including advice on modifiable risk factors and 
medications
Fig. 1 The OMA programme. Preparation and Training stages facilitate the use of three clinic tools (CDSS, GP letter and patient leaflets)
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hypothetical scenarios. Insights from these processes were
used to modify the CDSS in line with working practices,
and to inform a training session for the finalised CDSS.
Initially planned as a CDSS based on expert panel consen-
sus, the CDSS was modified in March 2010 to incorporate
newly published UK guidance from the National Institute
for Health and Care Excellence (NICE CG95) [9]. This
modified CDSS was again discussed with clinicians and
feedback sought in a clinician focus group, before final
modifications and subsequent testing within the pilot study
presented here. Prior to its use in practice, in a training ses-
sion at each site (training stage) we described the rationale
for the CDSS and CDSS recommendations were developed,
and facilitated discussion of how to use the tool in practice
using case scenarios. Clinicians were invited by email to
attend the training session. Publicity for the OMA CDSS
was limited to the stages described in this section.
The CDSS was designed for use by any clinician assessing
and managing patients in the chest pain clinic setting. In
our study settings clinicians included cardiology specialist
nurses, cardiologists and cardiac physiologists. CDSS use
was optional for the physicians with no incentives for its
use. We were unable to integrate the CDSS with existing
electronic systems; clinicians entered data about each
patient manually. Clinicians enter clinical information
required to calculate a patient’s pre-test probability for
coronary heart disease [10], on which investigation and
medication recommendations are based (Fig. 2). Forindividuals with a pre-test probability of coronary disease
of <90 % investigation recommendations were based on
NICE guidance [9]. The NICE guidelines do not give
investigation recommendations for individuals with a pre-
test probability of coronary disease of >90 %. A panel of
12 cardiac clinicians agreed that these patients should all
have angiography unless there were contraindications to
further treatment. CDSS medication recommendations
were provided by the panel, and included recommenda-
tions for up to three drug classes: anti-platelets, statins
and beta-blockers. After receiving recommendations from
the CDSS, clinicians were prompted to record their agree-
ment or disagreement with the recommendations and the
reasons for these.
Quantitative data collection and analysis
The following data were extracted from the clinic record
at presentation to the clinic: age, sex, cardiovascular risk
factors, resting ECG and typicality of chest pain. These
data were collected from the CDSS when it had been used,
and from the clinic record for all other patients. When the
CDSS was not used, two members of the research team
(AT and MJZ) labelled the chest pain as typical, atypical or
non-cardiac based on the hospital record. Medications
(anti-platelets, beta-blockers and statins) current at the
clinic date were extracted from the primary care electronic
record.
Participants were followed up for six months. Prescrip-
tions of anti-platelet medication, beta-blockers and statins
Fig. 2 Screenshot of the OMA CDSS clinical data entry page
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the electronic primary care record. Cardiac investigations
(computerised tomography, calcium scoring, coronary angi-
ography, stress echocardiography, myocardial perfusion
scanning, angiography/angioplasty, cardiac MRI) performed
in the six months after the chest pain clinic were collected
from the hospital records.
Participants were analysed in two groups: patients seen
before delivery of the OMA programme (Before OMA)
and patients seen after delivery of the OMA programme
(After OMA). Concordance with the CDSS recommen-
dation of investigations done within six months and
medications prescribed at six months was determined
for the After OMA group. For patients for whom the
CDSS was not available (Before OMA) or not used (After
OMA), we used data from the clinic record to generate
CDSS recommendations, in order to determine whether
the investigations done and medications prescribed were
in line with what the CDSS would have recommended.
If we assume that CDSS recommendations would be
followed for 75 % of patients even without the use of
OMA, and that this percentage would increase to 85 %
when OMA was used, we would be required to study
354 patients with and without use of OMA (708 in all)
to detect this difference as statistically significant at 5 %
level, with 90 % power. As this was a feasibility study,
our sample size was based on pragmatic considerations:
the number of patients consulting at the chest pain
clinic over the course of the data collection phase of thestudy. We report only descriptive statistics, with 95 % con-
fidence intervals to convey the precision of estimates.
Qualitative data collection and analysis
We conducted a qualitative study in Trust A during the
four months following delivery of the OMA programme.
This included chest pain clinic observations, followed by
face-to-face interviews with clinicians, and a focus group
with clinicians after the CDSS had been in use for three
months. Observation enabled systematic inquiry into the
nature and quality of observable behaviours, in particu-
lar how the CDSS was incorporated into clinic practice.
Brief interviews with clinicians immediately after each
consultation encouraged reflection of the use and rele-
vance of the CDSS for individual cases. Longer inter-
views with clinicians following regular use of the CDSS
aimed to explore their overall views of the usefulness of
the tool. The observation data provided a means of con-
firming the accuracy of recall at interview. The focus
group allowed for discussion and exchange of views
amongst clinicians about the day-do-day benefits and
difficulties of using the CDSS and its potential imple-
mentation in practice. Purposive sampling was used for
clinic observations, to gain a maximum variation sample
across all clinicians, who worked on different days of the
week. Post-consultation field interviews were conducted
where feasible in between appointments.
Qualitative data were collected between July and
November 2010, and are summarised in Table 1. Trust B
Table 1 Qualitative data gathered after delivery of the OMA
programme
Data Type Data type Number Sites
Observational Post-intervention
consultations:
Trust A
Cardiologist 12
Specialist cardiac nurse 20
Physiologist 8
Total: 40
Self-reported Field interviews immediately Trust A
following observation
of CDSS
10
Cardiologist 9
Specialist cardiac nurse 6
Physiologist Total: 25
Clinician interviews 5 Trust A (4) and
aTrust B (1)
Cardiologist 2
Specialist cardiac nurse 3
Clinician focus group 1 Trust A
Participants:
Cardiologist1
Specialist cardiac nurse2
Physiologist 1
aInterview carried out with lead clinician at Trust B to explore diversity of
issues across sites
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integrate the CDSS at the first of these clinics due to
lack of internet facilities within the clinic. As a result the
CDSS was only used in the second chest pain clinic. The
resultant delay meant that the qualitative researchers
were no longer able to observe the introduction of the
chest pain clinic in Trust B.
Detailed field-notes and audio-recordings were made
of all observed consultations, including brief field inter-
views conducted at the end of consultations. All clinician
interviews and the focus group were audio-recorded.
Interview and consultation transcripts and observa-
tional field-notes were imported into qualitative data
analysis software (atlas.ti and Nvivo), coded and ana-
lysed thematically [11]. Four of the investigators (KB,
ME, RJ, HC) contributed to the identification of emer-
gent themes.
We linked transcripts and field notes for the observed
consultations to clinical information from patients’ med-
ical records and to the recommendations of the CDSS.
Insights from the case-by-case analysis of clinicians’ use
of the CDSS were synthesised with themes emerging
from the analysis of interview and focus group data. Staff
are numbered consecutively [S1, S2]. Data collected by
interview are indicated by [I]; data collected by observa-
tion are indicated by [OB]; field interview by [FI] andfocus group by [FG]. . Verbatim quotes are marked with
quotation marks.
This study has ethics approval (London-City Road and
Hampstead REC and Riverside Research Ethics Commit-
tee reference number 08/H0709/85), and research gov-
ernance approval (from NHS sites).Results
Before and after study
294 patients were recruited to the quantitative study be-
tween November 2009 and May 2011; 285 were included
in the analysis at six months (Fig. 3): 106 patients seen
in a clinic that had not received the OMA programme
(Before OMA) and 179 patients seen in a clinic that had
received the OMA programme (After OMA). Character-
istics at baseline (chest pain clinic consultation) includ-
ing cardiovascular risk factors and current medications
are shown in Table 2. Clinicians seeing patients in the
Before OMA group were cardiologists (3), specialist
cardiology nurses (2) and a cardiac physiologist (1), and
in the After OMA group were cardiologists (4), specialist
cardiology nurses (3) and a cardiac physiologist (1). The
CDSS was used for 86 % (154/179 95 CI 81–91 %) of
patients in the After OMA group. CDSS was used for 81
out of 100 patients (81 %) in Trust A, and 73 out of 79
patients (92 %) in Trust B (difference 11, 95 CI 2–21 %).
The CDSS recommended investigation in 34 % (95
CI 25–43 %) of patients Before OMA and 41 % (95 CI
34–48 %) of patients After OMA. Table 3 shows the
number of patients having any investigation done
within six months, by CDSS recommendation. The
proportion of patients for whom the CDSS recommen-
dation was followed was 74 % (95 CI 65–82 %) in the
Before OMA group and 75 % (95 CI 69–81 %) in the
After OMA group. The proportion of patients for
which the CDSS recommended no investigation that
did not have one was the same before and after the
OMA intervention. Where the CDSS recommended an
investigation, the proportion receiving an investigation
was 50 % [CI 34–66 %] in the Before OMA group and
59 % [95 CI 48–70 %] in the After OMA group. The
CDSS recommended an increase in the number of medi-
cation classes for 25 patients (24, 95 CI 16–32 %) Before
OMA. Of these, eight (32, 95 CI 14–50 %) patients
received at least one additional medication class, two (8
95 CI −3–19 %) received fewer medication classes and 15
(60, 95 CI 41–79 %) had no change. In the After OMA
group, the CDSS recommended an increase in the number
of medication classes for 34 (19, 95 CI 13–25 %) partici-
pants. Of these, 17 (50, 95 CI 33–67 %) were prescribed at
least 1 additional medication class, 7 (21, 95 CI 7–35 %)
were prescribed at least 1 fewer medication classes and 10
(29, 95 CI 14–44 %) were unchanged.
Fig. 3 Recruitment to the before and after study
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Although CDSS use was high, we found that clini-
cians used the CDSS differently than originallyintended. Case studies draw on observational and
interview data to illustrate the themes identified and
are found in Figs. 4 and 5.
Table 2 Baseline characteristics at date of chest pain clinic
consultation
BEFORE OMA AFTER OMA
N = 106 N = 179
Age Mean (SD) 59.4 (11.0) 59.0 (11.6)
Sex
Male 52 (49 %) 97 (54 %)
Female 54 (51 %) 82 (46 %)
Risk factors:
Smoking 43 (41 %) 59 (33 %)
Diabetes 9 (8 %) 20 (11 %)
Hyperlipidaemia 34(32 %) 62 (35 %)
Medications current at
chest pain clinic:
Anti-platelet 23 (22 %) 34 (19 %)
Beta-blocker 5 (5 %) 17 (9 %)
Statin 26 (25 %) 37 (21 %)
Typicality of chest pain:
Typical 20 (19 %) 46 (26 %)
Atypical 17 (16 %) 28 (16 %)
Non-cardiac 69 (65 %) 105 (59 %)
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CDSS Problems with initial pain categorisation
In the NICE guideline chest pain is labelled as ‘typical’,
‘atypical’ or ‘non-anginal’ depending on the answers to
three questions (Fig. 6) [9]. However, through observa-
tion it became clear that clinicians viewed translating
patient reported symptoms into these three categories as
problematic (see Figs. 4, 5, 7, 8 and 9). Use of the pain
labels required a change to their usual practice, and the
use of the label ‘atypical’ was frequently problematic. For
example, one nurse described how she felt most of the
chest pain clinicians used the term ‘atypical’ where pain
was not thought to be cardiac but there was uncertainty.
Others described a reluctance to use the term ‘non-an-
ginal’ because of its diagnostic certainty, and there wereTable 3 Agreement of investigations with CDSS recommendations
Investigation done
Before OMA CDSS recommendation (investigation or no investigation)
followed in 78 out of 106 cases (74, 95 CI 65–82 %)
CDSS recommends:- n Done % done (95 % CI)
Investigation 36 18 50 (34–66)
No investigation 70 10 14 (6–22)
After OMA CDSS recommendation (investigation or no investigation)
followed in 134 out of 179 cases (75, 95 CI 69–81 %)
CDSS recommends:-
Investigation 74 44 59 (48–70)
No investigation 105 15 14 (7–21)examples of clinicians entering the description ‘atypical’
while saying that they were sure that the pain was non-
cardiac. Although one nurse said that in responding to
the questions he would try and stick closely to the pa-
tient’s report of their symptoms regardless of his own
hunches, researchers also observed clinicians consciously
answering the pain quality questions in a particular way
to match their clinical judgment or to manipulate a par-
ticular CDSS response. In some cases, patients’ stories
changed during the consultation. Further, clinicians de-
scribed the skill required in eliciting ‘the whole story’ of
chest pain from a patient, of which the three diagnostic
questions represented only a part.
Dissatisfaction with entering risk factors as binary
information
Clinicians expressed concern that the CDSS did not allow
them to grade information about patients’ cardiovascular
risk factors, as they felt entering these factors in binary
form (present or absent) omitted important details they
had available to them. For example, patients with particu-
larly high cholesterol levels were considered to be at higher
risk, yet this level of detail was not captured by the CDSS.
Although the clinicians understood that the algorithm
underlying the CDSS was based on diagnostic and prognos-
tic research evidence, this did not reflect the way in which
they understood and weighted risk factors in practice. For
example, clinicians expressed frustration that risk factors
that they routinely used in clinical practice, in particular
family history, did not affect the CDSS recommendations.
Inability to discount available information: the exercise
electrocardiogram
During the study, the treadmill exercise electrocardiogram
(exercise tolerance test, ETT) was still used to assess most
patients. However, in line with NICE guidance, the CDSS
algorithm did not incorporate the results of the ETT. Clini-
cians were unwilling to ignore additional information from
the ETT and one clinician explained that she would use the
CDSS only after she had interpreted the ETT so as to not
‘cloud her judgment’. At the same time, they acknowledged
the limitations of the ETT’s diagnostic value. Case studies 3
and 4 provide examples of clinicians’ interpretations of the
patient history changing during the course of the consult-
ation. Case studies 2, 5 and 6 are examples where patients’
ETT performance contributed to clinicians’ decision to
deviate from CDSS recommendations.
Structural and practical barriers to using the CDSS as
intended
Structural barriers to implementing the CDSS recommen-
dations included inability of clinicians other than doctors to
prescribe medication, and the unavailability of specific im-
aging methods at the hospital site. Authorised prescribers
Fig. 4 Case studies
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Fig. 5 Case studies
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medication from the hospital pharmacy. Reasons cited for
this were clinicians not being in the habit of prescribing (it
was their usual practice to issue recommendations to the
patient’s GP), GPs having a better grasp of how medication
fitted with patients’ existing drug regimen and additional
cost to the hospital trust. Clinicians chose readily access-
ible investigations over those with limited availability (CT
angiography) or longer waiting times (stress echocardiog-
raphy) at the time of the study; this often led to choosing
different investigations to those recommended by the
CDSS. Clinicians also had to complete separate electronic
records with similar information to that requested by the
CDSS, which posed a competing demand and felt like du-
plication of effort.Impact of the CDSS on clinicians’ diagnostic decision–
making and patient management
The impact of the CDSS on diagnostic decision making
and patient management are illustrated in Figs. 4 and
Fig. 10. Clinicians disagreed with CDSS recommendations
about investigative procedures in almost half of all ob-
served cases. Clinician disagreement encompassed both
more and less investigations than recommended by the
CDSS. Researcher observations confirmed that, in all these
cases, clinicians stuck to their original decision instead of
considering changes in light of the CDSS recommenda-
tions. Indeed, there was a broad consensus amongst clini-
cians articulated in interviews and the focus group that
clinical decision-making could not and should not be
driven by technology and that clinicians should remain
Fig. 6 Classification of chest pain. Source: NICE CG95 [9]
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described the possible benefits to themselves of using the
CDSS mainly in terms of providing reassurance and sup-
porting a systematic approach to conducting consulta-
tions. This orientation towards the CDSS as ‘decision
feedback’ rather than ‘decision support’ was also reflected
in the timing of clinicians’ engagement with the CDSS. In
two thirds of the observed cases, clinicians used the CDSS
after they had communicated their decision to the patient
and the patient had left the room.
Clinicians were most likely to agree with the CDSS
guidance when pain was categorised as ‘non-anginal’,
resulting in a recommendation of ‘no further investiga-
tion’. For some typical case presentations of angina
symptoms clinicians also expressed agreement with
CDSS recommendations in theory, though in practice
they ‘downgraded’ the recommended methods of investi-
gation in a few cases where they felt that a more aggres-
sive approach was not in the patient’s best interest or
clinically unwarranted (see Case studies 6 and 7 for
examples). Clinicians were most likely to disagree with
the CDSS when they had categorised the patient’s pain
as ‘atypical’. In several of these cases the clinician had
expressed certainty that the pain was ‘non-anginal’ but
had entered it as atypical, leading to a recommendation
for further investigation. Often clinicians were swayed
by the presence of marked risk factors to investigate
patients in the face of recommendations not to do so. In
many cases the results of the exercise test were observed
to influence the decision to investigate further. Case stud-
ies 1,2,3, and 5 provide examples of such instances of dis-
agreement. Clinicians regarded CDSS recommendations
as most reliable and trustworthy - but probably also least
needed - when case histories were clearly typical for an-
gina or clearly non-anginal.
Discussion
Our study contributes new findings to the understanding
of how a CDSS is used in the initial management of a
common symptom. Despite use of the OMA CDSS in
86 % of consultations for which it was available, there waslittle evidence of impact on medication prescribing or on
investigation choice. Through qualitative data analysis we
gained an in-depth understanding of the reasons for this
discrepancy. We identified problems in entering patient
data into the CDSS. These included difficulties in classifi-
cation of symptoms and risk factors, and in the incorpor-
ation of all available clinical information emerging during
the consultation. In the majority of observed cases, the
CDSS was used after the patient had left the room. Struc-
tural and practical barriers to the use of the CDSS in-
cluded the availability of investigations and the prescribing
competencies of the clinicians. Analysis of observational
data revealed how clinicians privileged their clinical
expertise over CDSS advice, responding to CDSS recom-
mendations as ‘decision feedback’ rather than ‘decision
support’. There was most disagreement with CDSS rec-
ommendations for patients whose pain was categorised as
atypical, the group for which mapping patient symptoms
to the CDSS had proved most challenging. Chest pain cli-
nicians were rarely observed prescribing medication from
the clinic. Taken together these data indicate little chance
of the OMA CDSS influencing clinical outcomes, and as
such we will not proceed to a cluster randomized con-
trolled trial of the OMA CDSS.
Observing consultations in a chest pain clinic, Somerville
and colleagues [12] found that doctors were engaged in
practical interpretive work, actively restructuring patient
narratives to meet an accepted diagnostic classification.
Pain narratives were sometimes unstable and changing,
and symptoms outside the canon were investigated less
frequently. We have observed clinicians engaged in this
interpretive work, but also struggling to use a classifica-
tion that was sometimes at odds with their usual way of
working, despite our efforts during CDSS development to
understand clincians’ working practices. Our clinicians
worked creatively with the constraints of the tool, in line
with Berg’s description of how protocols for care can be
circumvented, tinkered with and interpreted in many
different ways [13]. We observed clinicians developing
‘workarounds’ to enable the system to be used, introdu-
cing the potential for unintended consequences of CDSS
use [14]. Previous qualitative studies have identified
CDSSs having little impact on decisions either through
non-use of the CDSS [15], or use after the consultation
has been completed [16]. A study of nurses using CDSS
identified how they were primarily used to confirm
decisions that had already been made [17].
The OMA CDSS delivered a national clinical guideline
through patient specific recommendations. The constrain-
ing effects of guidelines have been previously articulated,
including ignoring data that cannot easily be measured, and
failing to allow the tailoring of advice to individual patients
[18, 19]. A major limitation of guidelines is their poor fit to
complex clinical problems, particularly in the presence of
Fig. 7 Problems with entry of patient information into the CDSS
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ward clinical decisions, [20]. From our findings, this limita-
tion extends to CDSSs.
A strength of our study lies in its mixed methods ap-
proach. Although the quantitative data suggested that the
CDSS was used, the qualitative data were essential in
developing a more complete understanding of how it wasused. A limitation of the quantitative study was its rela-
tively small sample size, precluding statistical analysis. It is
possible that some appropriate investigations may have
happened after six months, at which point our follow-up
date was censored, so this was a conservative assessment
of adherence to investigation recommendations. We have
measured medication prescription in general practice six
Fig. 8 Problems with entry of patient information into the CDSS
Johnson et al. BMC Medical Informatics and Decision Making  (2015) 15:71 Page 12 of 15months after the chest pain clinic visit, as a proxy for suc-
cessful commencement or recommendation of long term
secondary prevention medication at the time of the clinic.
There are many other factors affecting whether medica-
tion is continued at six months, such as emergent indica-
tions for medication. Although CDSS use in both trustswas high, it appeared to be significantly different between
Trust A and B. A limitation of the qualitative study is that
were unable to observe Trust B after the introduction of
the CDSS.
The OMA CDSS was introduced at a time of transition
for chest pain services, the NICE guidance on which it was
Fig. 9 Problems with entry of patient information into the CDSS
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time, the ETT test played a central role in chest pain clinic
routines, and our main qualitative study site did not
routinely use computerised tomography or computer tom-
ography coronary angiography for the diagnosis of angina.
The NICE guidance advised against the use of the ETT,
and recommended increased numbers of non-invasive tests
including computerised tomography investigations. We
found that the failure of the guidance to incorporate a test
that was an entrenched part of chest pain clinic practice
[21] added to the difficulties of the clinicians in using the
CDSS. It is possible that the CDSS would have been more
able to impact upon clinic processes when chest pain clinics
were more able to follow the guidance. We have reportedhow often clinicians’ choice to investigate agreed with the
CDSS recommendations (concordance). Although it might
be assumed that concordance with NICE guidance reflects
appropriate management, we acknowledge the limitations
of concordance in the assessment of CDSS. Concordance
may be affected by many and diverse things, for example
the structural and practical barriers identified in this study,
or the perceived appropriateness of the underpinning guid-
ance for a specific clinical scenario.Conclusions
The OMA CDSS, and its underpinning NICE guidance,
required contextualised and nuanced clinical information
Fig. 10 Impact of the CDSS on diagnostic decision-making and patient management
Johnson et al. BMC Medical Informatics and Decision Making  (2015) 15:71 Page 14 of 15to be categorised in a way that did not fit with clinicians’
ways of working. This, in combination with a belief on the
part of participating clinicians that clinical decision making
should not be driven by technology, meant that the CDSS
did not substantially inform individual patient management.
Qualitative methods, proved essential in deepening our
understanding of the factors affecting CDSS use. Use of
the CDSS may have been improved by the provision of
guidance for both practitioners and patients [5] and a moreintensive training and monitoring programme [22]. CDSSs
for the assessment and management of new onset chest
pain may be more successful if they reflect more closely the
ways in which clinicians assess chest pain. Our study has ar-
ticulated barriers to CDSS use that need to be addressed in
the design of future interventions.
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